Martin Childers

Martin Childers

Company: Asklepios BioPharmaceutical

Job title: Chief Medical Officer


Martin K (Casey) Childers, D.O., PhD. Dr Childers is a graduate of Western University Health Sciences, Pomona, California (D.O.) and the University of Missouri, Columbia, Missouri (PhD, Physiology and Pharmacology). He was Chief Resident in Physical Medicine and Rehabilitation, University of Missouri (Diplomate, F.A.A.P.M&R). Dr Childers serves as Chief Medical Officer at Asklepios Biopharmaceutical, Inc. since 2017. He previously was a Professor at the University of Washington, Seattle, Washington, School of Medicine where he co-directed the MDA Care Center and the Institute for Stem Cell and Regenerative Medicine. His research group generated IND-enabling data to launch the first-in-human AAV gene therapy for X-linked myotubular myopathy in 2017. Dr. Childers’ main interests are in translational medicine applications for rare diseases focusing on gene transfer using AAV technology platforms.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.